How to treat MDS in a 70-year-old elderly patient

In general, MDS refers to myelodysplastic syndromes. The causes of myelodysplastic syndromes in a 70-year-old individual may include genetic factors, aging, exposure to chemical substances, history of cancer treatment, systemic lupus erythematosus, and others. Treatment under medical guidance may involve supportive care, medication, and other approaches. Specific analyses are as follows:

1. Genetics

Certain gene mutations or variations may increase an individual's susceptibility to myelodysplastic syndromes. These mutations may be inherited from parents or occur spontaneously during growth and development. Maintaining healthy lifestyle habits, balanced nutrition, and regular physical examinations can help with early detection and treatment.

2. Aging

With advancing age, the body's physiological functions gradually decline, including those of the hematopoietic system. In elderly individuals, both the number and function of hematopoietic stem cells in the bone marrow decrease, making them more vulnerable to external influences and increasing the risk of developing myelodysplastic syndromes. It is important to maintain a positive mindset, reduce stress, engage in moderate exercise, and strengthen overall physical health.

3. Chemical Exposure

Chemicals such as benzene and organic solvents may enter the body through occupational or environmental exposure or via certain medications, potentially damaging hematopoietic stem cells and leading to myelodysplastic syndromes. It is essential to avoid contact with known harmful chemicals. If working in environments with potential chemical exposure, appropriate protective equipment should be worn.

4. History of Cancer Treatment

Radiation therapy and chemotherapy, while effective in killing tumor cells, may also damage normal cells—including hematopoietic stem cells—potentially leading to the development of myelodysplastic syndromes. After cancer treatment, patients should follow medical advice for regular follow-up visits, ensure adequate nutrition, get sufficient rest, and support bodily recovery.

5. Systemic Lupus Erythematosus (SLE)

Systemic lupus erythematosus is an autoimmune disease in which the immune system mistakenly attacks the body's own healthy tissues, including the bone marrow. This may result in damage to hematopoietic stem cells and contribute to the development of myelodysplastic syndromes. SLE is typically accompanied by symptoms such as joint pain, rashes, and fever. Patients may take medications such as prednisone acetate tablets, methotrexate tablets, and tacrolimus ointment as directed by their physicians.

To prevent myelodysplastic syndromes, it is advisable to maintain healthy lifestyle habits, eat a balanced diet, avoid exposure to harmful chemicals, pay attention to mental well-being and engage in moderate physical activity, while closely monitoring any bodily changes and seeking timely medical evaluation when necessary.